Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at GIS's multiple
$1.0473.8% below market
0.94 ZNTL revenue / share×1.11x GIS P/S=$1.04
Market $3.99Implied $1.04
GIS · current priceP/S 1.11x
$38.29Latest market snapshot
Implied fair value · at ZNTL's multiple
$146.42282.4% above market
34.52 GIS revenue / share×4.24x ZNTL P/S=$146.42
Market $38.29Implied $146.42